Top compounds associated with response to INF2


Feature Type Standardized
Nominal ANOVA
mRNA triazolothiadiazine CTRPv2 pan-cancer AAC -0.14 4e-05
mRNA vincristine CTRPv2 pan-cancer AAC -0.14 4e-05
mRNA THZ-2-102-1 GDSC1000 pan-cancer AAC -0.13 7e-05
mRNA AZD6244 CTRPv2 pan-cancer AAC 0.16 8e-05
mRNA necrostatin-7 CTRPv2 pan-cancer AAC 0.17 8e-05
mRNA selumetinib:BRD-A02303741 (4:1 mol/mol) CTRPv2 pan-cancer AAC 0.15 9e-05
mRNA parbendazole CTRPv2 pan-cancer AAC -0.14 0.0001
mRNA FQI-1 CTRPv2 pan-cancer AAC -0.2 0.0002
mRNA selumetinib:navitoclax (8:1 mol/mol) CTRPv2 pan-cancer AAC 0.15 0.0003
mRNA PI-103 GDSC1000 pan-cancer AAC -0.12 0.0003
Download CSV